Serum Visfatin Levels Should Be Evaluated with Further Markers of Endothelial Inflammation

We read the article Elevated Serum Visfatin Levels in Patients with Acute Myocardial Infarction written by Mazaherioun et al. with interest. The authors aimed to assess any potential relationship between blood visfatin levels, anthropometric variables, and known risk factors of atherosclerosis and acute myocardial infarction (AMI). They determined that serum visfatin levels were significantly higher in AMI patients compared to controls. This finding was consistent with other studies that have shown a contribution of visfatin to atherosclerosis and plaque destabilization which, in turn, leads to myocardial infarction. We believe that these findings will act as a guide for further studies about risk factors of atherosclerosis and AMI.